Explore the latest in vaccination, including recent advances in child and adult immunization and studies of vaccine refusal and safety.
This Medical News article discusses the new COVID-19 vaccine and recommendations for fall 2023.
This study examines the association of the receipt of wild-type BNT162b2 vaccine with medically attended COVID-19 outcomes among children younger than 5 years in the US.
This secondary analysis of the INVESTED randomized clinical trial assesses whether high-dose compared with standard-dose influenza vaccine was temporally associated with cardiovascular (CV) events among patients with high-risk CV disease during periods of high influenza-like illness activity.
This Medical News article discusses EG.5, the Omicron descendant that could soon dominate globally.
This Viewpoint addresses the state of COVID-19 as of fall 2023 in the US and summarizes key clinical information for health care professionals and patients.
This randomized clinical trial examines a technology-based promotion of free seasonal influenza information and vaccination for Hong Kong residents 65 years or older.
This Viewpoint discusses whether routine vaccination is safe for children with MT-RNR1 gene variants that predispose to aminoglycoside-induced hearing loss.
This cohort study compares the reactogenicity and immunogenicity of COVID-19 and influenza vaccinations administered together with those of COVID-19 vaccination alone.
This JAMA Forum discusses Title VII challenges to vaccination mandates, the Groff v DeJoy decision, and the implications of the decision for health care employers.
Authors of this Viewpoint discuss the recent “pause” of the NIH Common Fund’s research program that was designed to study the communication of science and the possible detrimental effect of not addressing scientific misinformation and disinformation.
This Viewpoint discusses policies toward increasing access to effective COVID-19 vaccines, advancing vaccine equity, strengthening reimbursement policies, and increasing federal incentives for insurers and health systems to improve COVID-19 vaccine uptake.
This cohort study examines whether different vaccines are associated with multiple sclerosis flare-ups requiring hospitalization.
This case series uses postmarketing data to evaluate the incidence of injection site necrosis after 23-valent pneumococcal vaccine use in the global market.
This cross-sectional study examines the differences in excess death rates between Republican and Democratic voters in Florida and Ohio after the COVID-19 vaccine became available for all adults.
Customize your JAMA Network experience by selecting one or more topics from the list below.